Literature DB >> 32385950

First-in-human transcatheter pledget-assisted suture tricuspid annuloplasty for severe tricuspid insufficiency.

Adam B Greenbaum1,2, Jaffar M Khan3,4, Toby Rogers3,4, Vasilis C Babaliaros1, Marvin H K Eng2, Dee Dee Wang2, Gaetano Paone2, Robert J Lederman3.   

Abstract

OBJECTIVES: We report the first pledget-assisted suture tricuspid annuloplasty (PASTA) in a patient with torrential tricuspid regurgitation (TR).
BACKGROUND: Tricuspid valve regurgitation is a common malignant disease with no commercially available transcatheter therapy. PASTA is a "percutaneous surgical" procedure using pledgeted sutures to create a double-orifice tricuspid valve.
METHODS: An 83-year-old man had end-stage TR caused by a defibrillator lead. He consented to undergo PASTA on a compassionate basis. A double-orifice valve was created with pledgeted sutures from percutaneous right ventricular apical access.
RESULTS: TR was reduced from torrential to trace. The vena contracta reduced to from 23 to 1 mm and annular area reduced from 1817 to 782 mm2 . However, the annulus dehisced and required closure with a percutaneous nitinol plug. The patient was discharged home and was alive 6 months later but with persistent symptoms.
CONCLUSIONS: The anatomy of a double-orifice valve can eliminate TR but a better solution is required to avoid excessive suture tension on annular tissue. Published 2020. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  percutaneous tricuspid valve repair; transcatheter electrosurgery; tricuspid valve regurgitation

Mesh:

Year:  2020        PMID: 32385950      PMCID: PMC7648719          DOI: 10.1002/ccd.28955

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.585


  6 in total

1.  Transcatheter pledget-assisted suture tricuspid annuloplasty (PASTA) to create a double-orifice valve.

Authors:  Jaffar M Khan; Toby Rogers; William H Schenke; Adam B Greenbaum; Vasilis C Babaliaros; Gaetano Paone; Rajiv Ramasawmy; Marcus Y Chen; Daniel A Herzka; Robert J Lederman
Journal:  Catheter Cardiovasc Interv       Date:  2018-02-06       Impact factor: 2.692

2.  How to do the double orifice valve technique to treat tricuspid valve incompetence.

Authors:  Roland Hetzer; Takeshi Komoda; Eva Maria Delmo Walter
Journal:  Eur J Cardiothorac Surg       Date:  2012-09-03       Impact factor: 4.191

3.  The Double-Orifice Valve Technique to Treat Tricuspid Valve Incompetence.

Authors:  Roland Hetzer; Mariano Javier; Eva Maria Delmo Walter
Journal:  J Heart Valve Dis       Date:  2016-01

4.  Trends and outcomes of tricuspid valve surgery in North America: an analysis of more than 50,000 patients from the Society of Thoracic Surgeons database.

Authors:  Arman Kilic; Paramita Saha-Chaudhuri; J Scott Rankin; John V Conte
Journal:  Ann Thorac Surg       Date:  2013-09-23       Impact factor: 4.330

5.  Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty: SCOUT Trial 30-Day Results.

Authors:  Rebecca T Hahn; Christopher U Meduri; Charles J Davidson; Scott Lim; Tamim M Nazif; Mark J Ricciardi; Vivek Rajagopal; Gorav Ailawadi; Mani A Vannan; James D Thomas; Dale Fowler; Stuart Rich; Randy Martin; Geraldine Ong; Adam Groothuis; Susheel Kodali
Journal:  J Am Coll Cardiol       Date:  2017-04-11       Impact factor: 24.094

6.  Impact of tricuspid regurgitation on long-term survival.

Authors:  Jayant Nath; Elyse Foster; Paul A Heidenreich
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

  6 in total
  2 in total

Review 1.  Transcatheter tricuspid valve interventions: Current status and future perspectives.

Authors:  Alberto Alperi; Marcel Almendárez; Rut Álvarez; Cesar Moris; Victor Leon; Iria Silva; Daniel Hernández-Vaquero; Isaac Pascual; Pablo Avanzas
Journal:  Front Cardiovasc Med       Date:  2022-09-14

2.  Salt Heat Treatment and Passivation to Improve the Corrosion Resistance of Nitinol (Ni-Ti).

Authors:  Inho Bae; Byung-Hoon Kim; Dong-Gon Kim; Ik-Bu Sohn; Seong-Won Yang
Journal:  Materials (Basel)       Date:  2021-12-16       Impact factor: 3.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.